Pacific Edge reported NZD294.46M in Ordinary Share Capital for its fiscal semester ending in September of 2024.


Ordinary Share Capital Change Date
Pacific Edge NZD 294.46M 58K Sep/2024
Paradigm Biopharmaceuticals AUD 253.24M 15.12M Dec/2024
PYC Therapeutics AUD 230.58M 0 Dec/2024
Telix Pharmaceuticals AUD 334.72M 252.68M Dec/2024